Agilent gets FDA approval for cancer diagnostic test

March 26, 2026 8:00 AM

Agilent Technologies Inc. (NYSE: A) received U.S. Food and Drug Administration approval for its PD-L1 IHC 22C3 pharmDx diagnostic test ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found